ELAVL1 and Hodgkins lymphoma: Leucci et al. showed that miR-9 contributes to the pathogenesis of HL by targeting dicer 1, ribonuclease III (DICER1) and ELAV like RNA binding protein 1 (ELAVL1, also known as HUR) and thus affecting the cytokine production; moreover, inhibition of miR-9 in xenograft HL models leads to the reduction of tumor outgrowth [207].